These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 9553667)

  • 1. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of receptors for epidermal growth factor and insulin-like growth factor I by ZR-75-1 human breast cancer cell variants is inversely related: the effect of steroid hormones on insulin-like growth factor I receptor expression.
    van den Berg HW; Claffie D; Boylan M; McKillen J; Lynch M; McKibben B
    Br J Cancer; 1996 Feb; 73(4):477-81. PubMed ID: 8595162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast cancer cell line.
    Long B; McKibben BM; Lynch M; van den Berg HW
    Br J Cancer; 1992 Jun; 65(6):865-9. PubMed ID: 1616857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-proliferative effects of tyrosine kinase inhibitors towards tamoxifen-sensitive and tamoxifen-resistant human breast cancer cell lines in relation to the expression of epidermal growth factor receptors (EGF-R) and the inhibition of EGF-R tyrosine kinase.
    El-Zarruk AA; van den Berg HW
    Cancer Lett; 1999 Aug; 142(2):185-93. PubMed ID: 10463775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.
    Hutcheson IR; Knowlden JM; Madden TA; Barrow D; Gee JM; Wakeling AE; Nicholson RI
    Breast Cancer Res Treat; 2003 Sep; 81(1):81-93. PubMed ID: 14531500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of a tamoxifen-resistant variant of the ZR-75-1 human breast cancer cell line (ZR-75-9a1) and ability of the resistant phenotype.
    van den Berg HW; Lynch M; Martin J; Nelson J; Dickson GR; Crockard AD
    Br J Cancer; 1989 Apr; 59(4):522-6. PubMed ID: 2713239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the secretion of insulin-like growth factor binding proteins -2 and -4 associated with the development of tamoxifen resistance and estrogen independence in human breast cancer cell lines.
    Maxwell P; van den Berg HW
    Cancer Lett; 1999 May; 139(2):121-7. PubMed ID: 10395168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in insulin-like growth factor-I receptor expression and binding protein secretion associated with tamoxifen resistance and estrogen independence in human breast cancer cells in vitro.
    McCotter D; van den Berg HW; Boylan M; McKibben B
    Cancer Lett; 1996 Feb; 99(2):239-45. PubMed ID: 8616830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.
    Herman ME; Katzenellenbogen BS
    J Steroid Biochem Mol Biol; 1996 Oct; 59(2):121-34. PubMed ID: 9010327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
    Knowlden JM; Hutcheson IR; Barrow D; Gee JM; Nicholson RI
    Endocrinology; 2005 Nov; 146(11):4609-18. PubMed ID: 16037379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the development of resistance to the pure antiestrogen Faslodex in three human breast cancer cell lines.
    Sommer A; Hoffmann J; Lichtner RB; Schneider MR; Parczyk K
    J Steroid Biochem Mol Biol; 2003 May; 85(1):33-47. PubMed ID: 12798355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer.
    Gee JM; Robertson JF; Gutteridge E; Ellis IO; Pinder SE; Rubini M; Nicholson RI
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S99-S111. PubMed ID: 16113104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells.
    Wiseman LR; Johnson MD; Wakeling AE; Lykkesfeldt AE; May FE; Westley BR
    Eur J Cancer; 1993; 29A(16):2256-64. PubMed ID: 8110496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suramin-induced growth inhibition and insulin-like growth factor-I binding blockade in human breast carcinoma cell lines: potentially related events.
    Ravera F; Miglietta L; Pirani P; Ferrini S; Favoni RE
    Eur J Cancer; 1993; 29A(2):225-30. PubMed ID: 8422287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human interferon alpha increases oestrogen receptor expression in human breast cancer cells (ZR-75-1) and sensitizes them to the anti-proliferative effects of tamoxifen.
    van den Berg HW; Leahey WJ; Lynch M; Clarke R; Nelson J
    Br J Cancer; 1987 Mar; 55(3):255-7. PubMed ID: 3567059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen-induced epigenetic silencing of oestrogen-regulated genes in anti-hormone resistant breast cancer.
    Stone A; Valdés-Mora F; Gee JM; Farrow L; McClelland RA; Fiegl H; Dutkowski C; McCloy RA; Sutherland RL; Musgrove EA; Nicholson RI
    PLoS One; 2012; 7(7):e40466. PubMed ID: 22808167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.
    Chan CM; Martin LA; Johnston SR; Ali S; Dowsett M
    J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):333-41. PubMed ID: 12361723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment.
    Lykkesfeldt AE; Larsen SS; Briand P
    Int J Cancer; 1995 May; 61(4):529-34. PubMed ID: 7759159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.